Story · Public Health · Medicine & Biotech

CVS white paper aims to pressure drugmakers to lower GLP-1 prices

1 outlet · first reported by Healthcare Dive on

GLP-1s would save employers money in the long term if they were priced at $350 a month or less, the pharmacy juggernaut found. “I would love to see this pressure [drugmakers] to bring down prices to something rational,” CMO Amy Compton-Phillips said. (Healthcare Dive)

Coverage, in order

  1. CVS white paper aims to pressure drugmakers to lower GLP-1 prices

    GLP-1s would save employers money in the long term if they were priced at $350 a month or less, the pharmacy juggernaut found. “I would love to see this pressure [drugmakers] to bring down prices to something rational,” CMO Amy Compton-Phillips said.

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.